Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Remestemcel-L (Primary) ; Antithymocyte globulin; Basiliximab; Ciclosporin; Methylprednisolone; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
Most Recent Events
- 09 Apr 2015 Biomarkers information updated
- 18 Jul 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 04 May 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2009-012350-20).